Literature DB >> 6333994

Structural and functional characterization of the abnormal Z alpha 1-antitrypsin isolated from human liver.

I C Bathurst, J Travis, P M George, R W Carrell.   

Abstract

alpha 1-Antitrypsin has been isolated from liver inclusion bodies of a subject with a homozygous Z deficiency. The inhibitor was recovered in a fully active form by extraction in high salt at either pH 2.0 or pH 8.0. Carbohydrate analysis indicated a protein in the 'high mannose' form, and this was collaborated by its sensitivity to endo-beta N-glucosaminidase. These data suggest that the abnormal alpha 1-antitrypsin is blocked in the secretory pathway prior to its entrance into the Golgi, and that this blockage is not due to a gross misfolding of the polypeptide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333994     DOI: 10.1016/0014-5793(84)81279-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response.

Authors:  Catherine M Greene; Noel G McElvaney
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

2.  Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.

Authors:  A A McCracken; K B Kruse; J L Brown
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

Review 3.  alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.

Authors:  R W Carrell
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

4.  The cellular defect in alpha 1-proteinase inhibitor (alpha 1-PI) deficiency is expressed in human monocytes and in Xenopus oocytes injected with human liver mRNA.

Authors:  D H Perlmutter; R M Kay; F S Cole; T H Rossing; D Van Thiel; H R Colten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

5.  Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice.

Authors:  R N Sifers; J A Carlson; S M Clift; F J DeMayo; D W Bullock; S L Woo
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

6.  Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.

Authors:  J A Burrows; L K Willis; D H Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

7.  Biochemical characterization of a neuroserpin variant associated with hereditary dementia.

Authors:  M Yazaki; J J Liepnieks; J R Murrell; M Takao; B Guenther; P Piccardo; M R Farlow; B Ghetti; M D Benson
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

8.  Selective protein degradation in the yeast exocytic pathway.

Authors:  A A McCracken; K B Kruse
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

9.  The endosomal protein-sorting receptor sortilin has a role in trafficking α-1 antitrypsin.

Authors:  Cristy L Gelling; Ian W Dawes; David H Perlmutter; Edward A Fisher; Jeffrey L Brodsky
Journal:  Genetics       Date:  2012-08-24       Impact factor: 4.562

10.  Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency.

Authors:  Caitriona McLean; Catherine M Greene; Noel G McElvaney
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.